Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Go back to Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 158.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.07 | 52 Week High | $0.52 | |||
| Open | $152.50 | 52 Week Low | $0.08 | |||
| Day High | $161.96 | P/E | N/A | |||
| Day Low | $149.50 | EPS | $-3.80 | |||
| Volume | 90,837 | |||||
